Abstract
A series of symmetric molecules incorporating aryl or pyridyl moieties as central core and 1,4-substituted triazoles as a side bridge was synthesised. The new compounds were investigated as lactate dehydro-genase (LDH, EC 1.1.1.27) inhibitors. The cancer associated LDHA isoform was inhibited with IC50 = 117-174 µM. Seven compounds exhibited better LDHA inhibition (IC50 117-136 µM) compared to known LDH inhibitor - galloflavin (IC50 157 µM).
Keywords:
Lactate dehydrogenase; inhibitors; triazole.
MeSH terms
-
Dose-Response Relationship, Drug
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology*
-
Humans
-
Isocoumarins / chemistry
-
Isocoumarins / pharmacology*
-
L-Lactate Dehydrogenase / antagonists & inhibitors*
-
L-Lactate Dehydrogenase / metabolism
-
Molecular Structure
-
Structure-Activity Relationship
-
Triazoles / chemistry
-
Triazoles / pharmacology*
Substances
-
Enzyme Inhibitors
-
Isocoumarins
-
Triazoles
-
galloflavin
-
L-Lactate Dehydrogenase
Grants and funding
This project was supported by the National Plan of Science, Technology and Innovation [Grant No. 12-MED2980–54], Prince Sattam bin Abdulaziz University, Alkharj, PO Box 173, 11942.